TCPG_HUMAN - dbPTM
TCPG_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TCPG_HUMAN
UniProt AC P49368
Protein Name T-complex protein 1 subunit gamma
Gene Name CCT3
Organism Homo sapiens (Human).
Sequence Length 545
Subcellular Localization Cytoplasm.
Protein Description Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. As part of the BBS/CCT complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Known to play a role, in vitro, in the folding of actin and tubulin..
Protein Sequence MMGHRPVLVLSQNTKRESGRKVQSGNINAAKTIADIIRTCLGPKSMMKMLLDPMGGIVMTNDGNAILREIQVQHPAAKSMIEISRTQDEEVGDGTTSVIILAGEMLSVAEHFLEQQMHPTVVISAYRKALDDMISTLKKISIPVDISDSDMMLNIINSSITTKAISRWSSLACNIALDAVKMVQFEENGRKEIDIKKYARVEKIPGGIIEDSCVLRGVMINKDVTHPRMRRYIKNPRIVLLDSSLEYKKGESQTDIEITREEDFTRILQMEEEYIQQLCEDIIQLKPDVVITEKGISDLAQHYLMRANITAIRRVRKTDNNRIARACGARIVSRPEELREDDVGTGAGLLEIKKIGDEYFTFITDCKDPKACTILLRGASKEILSEVERNLQDAMQVCRNVLLDPQLVPGGGASEMAVAHALTEKSKAMTGVEQWPYRAVAQALEVIPRTLIQNCGASTIRLLTSLRAKHTQENCETWGVNGETGTLVDMKELGIWEPLAVKLQTYKTAVETAVLLLRIDDIVSGHKKKGDDQSRQGGAPDAGQE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MMGHRPVL
-------CCCCCCEE
7.0119413330
5Methylation---MMGHRPVLVLSQ
---CCCCCCEEEEEC
19.79-
11PhosphorylationHRPVLVLSQNTKRES
CCCEEEEECCCCCCC
17.5720068231
14PhosphorylationVLVLSQNTKRESGRK
EEEEECCCCCCCCCC
24.6820068231
152-HydroxyisobutyrylationLVLSQNTKRESGRKV
EEEECCCCCCCCCCC
62.81-
15AcetylationLVLSQNTKRESGRKV
EEEECCCCCCCCCCC
62.8125953088
15MalonylationLVLSQNTKRESGRKV
EEEECCCCCCCCCCC
62.8126320211
15SumoylationLVLSQNTKRESGRKV
EEEECCCCCCCCCCC
62.8128112733
15UbiquitinationLVLSQNTKRESGRKV
EEEECCCCCCCCCCC
62.81-
18PhosphorylationSQNTKRESGRKVQSG
ECCCCCCCCCCCCCC
48.1826074081
21AcetylationTKRESGRKVQSGNIN
CCCCCCCCCCCCCCC
48.4220167786
21UbiquitinationTKRESGRKVQSGNIN
CCCCCCCCCCCCCCC
48.4221906983
24PhosphorylationESGRKVQSGNINAAK
CCCCCCCCCCCCHHH
36.4720068231
24 (in isoform 2)Phosphorylation-36.4720068231
31AcetylationSGNINAAKTIADIIR
CCCCCHHHHHHHHHH
37.7520167786
31SuccinylationSGNINAAKTIADIIR
CCCCCHHHHHHHHHH
37.7523954790
31UbiquitinationSGNINAAKTIADIIR
CCCCCHHHHHHHHHH
37.7521890473
32PhosphorylationGNINAAKTIADIIRT
CCCCHHHHHHHHHHH
19.3723882029
44AcetylationIRTCLGPKSMMKMLL
HHHHHCHHHHHHHHH
49.5420167786
44UbiquitinationIRTCLGPKSMMKMLL
HHHHHCHHHHHHHHH
49.5421906983
45PhosphorylationRTCLGPKSMMKMLLD
HHHHCHHHHHHHHHC
27.5223532336
49SulfoxidationGPKSMMKMLLDPMGG
CHHHHHHHHHCCCCC
2.1521406390
78AcetylationQVQHPAAKSMIEISR
EECCHHHHHHEEEEC
42.5425953088
78UbiquitinationQVQHPAAKSMIEISR
EECCHHHHHHEEEEC
42.5421906983
80SulfoxidationQHPAAKSMIEISRTQ
CCHHHHHHEEEECCC
2.9221406390
86PhosphorylationSMIEISRTQDEEVGD
HHEEEECCCCCCCCC
33.31-
90UbiquitinationISRTQDEEVGDGTTS
EECCCCCCCCCCCEE
61.1521890473
100UbiquitinationDGTTSVIILAGEMLS
CCCEEEEEEEHHHHH
1.7021890473
1282-HydroxyisobutyrylationVVISAYRKALDDMIS
HHHHHHHHHHHHHHH
40.39-
128UbiquitinationVVISAYRKALDDMIS
HHHHHHHHHHHHHHH
40.3921906983
133SulfoxidationYRKALDDMISTLKKI
HHHHHHHHHHHHHHC
2.3221406390
135PhosphorylationKALDDMISTLKKISI
HHHHHHHHHHHHCCC
22.5021406692
136PhosphorylationALDDMISTLKKISIP
HHHHHHHHHHHCCCC
31.5021406692
1382-HydroxyisobutyrylationDDMISTLKKISIPVD
HHHHHHHHHCCCCCC
48.42-
138AcetylationDDMISTLKKISIPVD
HHHHHHHHHCCCCCC
48.4223236377
138MalonylationDDMISTLKKISIPVD
HHHHHHHHHCCCCCC
48.4226320211
138UbiquitinationDDMISTLKKISIPVD
HHHHHHHHHCCCCCC
48.4221890473
139UbiquitinationDMISTLKKISIPVDI
HHHHHHHHCCCCCCC
44.8121906983
141PhosphorylationISTLKKISIPVDISD
HHHHHHCCCCCCCCC
29.7120068231
147PhosphorylationISIPVDISDSDMMLN
CCCCCCCCCCHHHHH
26.9720068231
149PhosphorylationIPVDISDSDMMLNII
CCCCCCCCHHHHHHH
22.1820068231
158PhosphorylationMMLNIINSSITTKAI
HHHHHHCCHHHHHHH
16.8320068231
159PhosphorylationMLNIINSSITTKAIS
HHHHHCCHHHHHHHH
21.3320068231
161PhosphorylationNIINSSITTKAISRW
HHHCCHHHHHHHHHH
24.9620068231
162PhosphorylationIINSSITTKAISRWS
HHCCHHHHHHHHHHH
19.4620068231
163UbiquitinationINSSITTKAISRWSS
HCCHHHHHHHHHHHH
34.76-
169PhosphorylationTKAISRWSSLACNIA
HHHHHHHHHHHHHHH
17.8623898821
170PhosphorylationKAISRWSSLACNIAL
HHHHHHHHHHHHHHH
17.0227050516
173S-nitrosocysteineSRWSSLACNIALDAV
HHHHHHHHHHHHHHH
4.61-
173GlutathionylationSRWSSLACNIALDAV
HHHHHHHHHHHHHHH
4.6122555962
173S-nitrosylationSRWSSLACNIALDAV
HHHHHHHHHHHHHHH
4.6122178444
181UbiquitinationNIALDAVKMVQFEEN
HHHHHHHHHEEEHHC
34.77-
182SulfoxidationIALDAVKMVQFEENG
HHHHHHHHEEEHHCC
2.0021406390
198PhosphorylationKEIDIKKYARVEKIP
EEEEHHHEEEEEECC
8.47-
203AcetylationKKYARVEKIPGGIIE
HHEEEEEECCCCCCC
51.8825953088
203MalonylationKKYARVEKIPGGIIE
HHEEEEEECCCCCCC
51.8826320211
203UbiquitinationKKYARVEKIPGGIIE
HHEEEEEECCCCCCC
51.88-
210UbiquitinationKIPGGIIEDSCVLRG
ECCCCCCCCCCEEEC
41.7821890473
213S-nitrosocysteineGGIIEDSCVLRGVMI
CCCCCCCCEEECEEE
5.31-
213GlutathionylationGGIIEDSCVLRGVMI
CCCCCCCCEEECEEE
5.3122555962
213S-nitrosylationGGIIEDSCVLRGVMI
CCCCCCCCEEECEEE
5.3122178444
216MethylationIEDSCVLRGVMINKD
CCCCCEEECEEECCC
18.44-
2222-HydroxyisobutyrylationLRGVMINKDVTHPRM
EECEEECCCCCCHHH
42.52-
222AcetylationLRGVMINKDVTHPRM
EECEEECCCCCCHHH
42.5219608861
222MalonylationLRGVMINKDVTHPRM
EECEEECCCCCCHHH
42.5226320211
222UbiquitinationLRGVMINKDVTHPRM
EECEEECCCCCCHHH
42.5219608861
225PhosphorylationVMINKDVTHPRMRRY
EEECCCCCCHHHHHH
35.9720068231
232PhosphorylationTHPRMRRYIKNPRIV
CCHHHHHHCCCCCEE
13.0924719451
234AcetylationPRMRRYIKNPRIVLL
HHHHHHCCCCCEEEE
52.5525953088
234UbiquitinationPRMRRYIKNPRIVLL
HHHHHHCCCCCEEEE
52.55-
243PhosphorylationPRIVLLDSSLEYKKG
CCEEEEECCCCCCCC
36.4719664994
244PhosphorylationRIVLLDSSLEYKKGE
CEEEEECCCCCCCCC
25.5319664994
247NitrationLLDSSLEYKKGESQT
EEECCCCCCCCCCCC
24.24-
247PhosphorylationLLDSSLEYKKGESQT
EEECCCCCCCCCCCC
24.2430576142
248AcetylationLDSSLEYKKGESQTD
EECCCCCCCCCCCCC
44.9523954790
248MalonylationLDSSLEYKKGESQTD
EECCCCCCCCCCCCC
44.9526320211
248SumoylationLDSSLEYKKGESQTD
EECCCCCCCCCCCCC
44.9528112733
248UbiquitinationLDSSLEYKKGESQTD
EECCCCCCCCCCCCC
44.9521906983
2492-HydroxyisobutyrylationDSSLEYKKGESQTDI
ECCCCCCCCCCCCCC
67.99-
249MalonylationDSSLEYKKGESQTDI
ECCCCCCCCCCCCCC
67.9926320211
249SumoylationDSSLEYKKGESQTDI
ECCCCCCCCCCCCCC
67.9928112733
249UbiquitinationDSSLEYKKGESQTDI
ECCCCCCCCCCCCCC
67.9920639865
252PhosphorylationLEYKKGESQTDIEIT
CCCCCCCCCCCCEEE
47.2329255136
254PhosphorylationYKKGESQTDIEITRE
CCCCCCCCCCEEECH
48.5023927012
259PhosphorylationSQTDIEITREEDFTR
CCCCCEEECHHHHHH
21.1629978859
265PhosphorylationITREEDFTRILQMEE
EECHHHHHHHHHCCH
29.1723927012
286UbiquitinationCEDIIQLKPDVVITE
HHHHHHCCCCEEEEC
23.85-
297PhosphorylationVITEKGISDLAQHYL
EEECCCHHHHHHHHH
34.9320068231
303PhosphorylationISDLAQHYLMRANIT
HHHHHHHHHHHCCHH
7.0720068231
305SulfoxidationDLAQHYLMRANITAI
HHHHHHHHHCCHHHH
2.7530846556
310PhosphorylationYLMRANITAIRRVRK
HHHHCCHHHHCCHHC
18.8124719451
313MethylationRANITAIRRVRKTDN
HCCHHHHCCHHCCCC
28.69-
317AcetylationTAIRRVRKTDNNRIA
HHHCCHHCCCCCHHH
58.3219818619
343UbiquitinationEELREDDVGTGAGLL
HHHCCCCCCCCCCEE
13.1421890473
3532-HydroxyisobutyrylationGAGLLEIKKIGDEYF
CCCEEEEEEECCEEE
29.03-
353AcetylationGAGLLEIKKIGDEYF
CCCEEEEEEECCEEE
29.0326051181
353UbiquitinationGAGLLEIKKIGDEYF
CCCEEEEEEECCEEE
29.0321906983
3542-HydroxyisobutyrylationAGLLEIKKIGDEYFT
CCEEEEEEECCEEEE
58.54-
354UbiquitinationAGLLEIKKIGDEYFT
CCEEEEEEECCEEEE
58.54-
359NitrationIKKIGDEYFTFITDC
EEEECCEEEEEEECC
16.80-
359PhosphorylationIKKIGDEYFTFITDC
EEEECCEEEEEEECC
16.8028152594
361PhosphorylationKIGDEYFTFITDCKD
EECCEEEEEEECCCC
17.1528152594
366GlutathionylationYFTFITDCKDPKACT
EEEEEECCCCHHHHE
3.9422555962
3672-HydroxyisobutyrylationFTFITDCKDPKACTI
EEEEECCCCHHHHEE
78.76-
367AcetylationFTFITDCKDPKACTI
EEEEECCCCHHHHEE
78.7626051181
367UbiquitinationFTFITDCKDPKACTI
EEEEECCCCHHHHEE
78.76-
3702-HydroxyisobutyrylationITDCKDPKACTILLR
EECCCCHHHHEEEEC
67.25-
370AcetylationITDCKDPKACTILLR
EECCCCHHHHEEEEC
67.2526051181
370UbiquitinationITDCKDPKACTILLR
EECCCCHHHHEEEEC
67.25-
372GlutathionylationDCKDPKACTILLRGA
CCCCHHHHEEEECCC
2.8022555962
377MethylationKACTILLRGASKEIL
HHHEEEECCCCHHHH
34.88-
380PhosphorylationTILLRGASKEILSEV
EEEECCCCHHHHHHH
33.3829514088
3812-HydroxyisobutyrylationILLRGASKEILSEVE
EEECCCCHHHHHHHH
48.52-
381AcetylationILLRGASKEILSEVE
EEECCCCHHHHHHHH
48.5223954790
381MalonylationILLRGASKEILSEVE
EEECCCCHHHHHHHH
48.5226320211
381SumoylationILLRGASKEILSEVE
EEECCCCHHHHHHHH
48.5225114211
381UbiquitinationILLRGASKEILSEVE
EEECCCCHHHHHHHH
48.5221890473
385PhosphorylationGASKEILSEVERNLQ
CCCHHHHHHHHHHHH
45.3021815630
395SulfoxidationERNLQDAMQVCRNVL
HHHHHHHHHHHHHHH
4.0621406390
398GlutathionylationLQDAMQVCRNVLLDP
HHHHHHHHHHHHCCC
1.1522555962
398S-palmitoylationLQDAMQVCRNVLLDP
HHHHHHHHHHHHCCC
1.1526865113
414PhosphorylationLVPGGGASEMAVAHA
CCCCCCHHHHHHHHH
31.0530622161
416SulfoxidationPGGGASEMAVAHALT
CCCCHHHHHHHHHHH
3.1730846556
423PhosphorylationMAVAHALTEKSKAMT
HHHHHHHHHHCCCCC
41.9925693802
4252-HydroxyisobutyrylationVAHALTEKSKAMTGV
HHHHHHHHCCCCCCC
52.61-
425UbiquitinationVAHALTEKSKAMTGV
HHHHHHHHCCCCCCC
52.6121906983
4272-HydroxyisobutyrylationHALTEKSKAMTGVEQ
HHHHHHCCCCCCCCC
53.93-
427UbiquitinationHALTEKSKAMTGVEQ
HHHHHHCCCCCCCCC
53.9321906983
430PhosphorylationTEKSKAMTGVEQWPY
HHHCCCCCCCCCCHH
42.8220068231
437PhosphorylationTGVEQWPYRAVAQAL
CCCCCCHHHHHHHHH
14.3020068231
450PhosphorylationALEVIPRTLIQNCGA
HHHHCCHHHHHHCCH
23.9023186163
455GlutathionylationPRTLIQNCGASTIRL
CHHHHHHCCHHHHHH
2.4922555962
455S-palmitoylationPRTLIQNCGASTIRL
CHHHHHHCCHHHHHH
2.4929575903
458PhosphorylationLIQNCGASTIRLLTS
HHHHCCHHHHHHHHH
15.0621712546
459PhosphorylationIQNCGASTIRLLTSL
HHHCCHHHHHHHHHH
15.0225072903
464UbiquitinationASTIRLLTSLRAKHT
HHHHHHHHHHHHHHC
30.2421890473
469UbiquitinationLLTSLRAKHTQENCE
HHHHHHHHHCHHCHH
40.5321890473
469AcetylationLLTSLRAKHTQENCE
HHHHHHHHHCHHCHH
40.5325953088
469UbiquitinationLLTSLRAKHTQENCE
HHHHHHHHHCHHCHH
40.53-
477PhosphorylationHTQENCETWGVNGET
HCHHCHHHCCCCCCC
29.71-
491UbiquitinationTGTLVDMKELGIWEP
CCEEEEHHHHCCCCC
45.37-
502UbiquitinationIWEPLAVKLQTYKTA
CCCCCHHHHHHHHHH
29.3021906983
507UbiquitinationAVKLQTYKTAVETAV
HHHHHHHHHHHHHHH
33.1421906983
508PhosphorylationVKLQTYKTAVETAVL
HHHHHHHHHHHHHHH
26.0621712546
512PhosphorylationTYKTAVETAVLLLRI
HHHHHHHHHHHHHHH
18.57-
524PhosphorylationLRIDDIVSGHKKKGD
HHHHHHHCCCCCCCC
35.2025159151
5272-HydroxyisobutyrylationDDIVSGHKKKGDDQS
HHHHCCCCCCCCCCC
60.76-
527AcetylationDDIVSGHKKKGDDQS
HHHHCCCCCCCCCCC
60.7626051181
527SuccinylationDDIVSGHKKKGDDQS
HHHHCCCCCCCCCCC
60.7623954790
527UbiquitinationDDIVSGHKKKGDDQS
HHHHCCCCCCCCCCC
60.76-
528UbiquitinationDIVSGHKKKGDDQSR
HHHCCCCCCCCCCCC
57.21-
529UbiquitinationIVSGHKKKGDDQSRQ
HHCCCCCCCCCCCCC
72.82-
534PhosphorylationKKKGDDQSRQGGAPD
CCCCCCCCCCCCCCC
33.3030576142

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TCPG_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TCPG_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TCPG_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SSA27_HUMANSSSCA1physical
16189514
EI2BB_HUMANEIF2B2physical
16169070
TCPH_HUMANCCT7physical
22939629
TCPQ_HUMANCCT8physical
22939629
TCPZ_HUMANCCT6Aphysical
22939629
TCPW_HUMANCCT6Bphysical
22939629
ACACA_HUMANACACAphysical
22863883
TCPH_HUMANCCT7physical
22863883
TIF1B_HUMANTRIM28physical
22863883
MIPO1_HUMANMIPOL1physical
25416956
TCPB_HUMANCCT2physical
26344197
TCPD_HUMANCCT4physical
26344197
TCPH_HUMANCCT7physical
26344197
TCPQ_HUMANCCT8physical
26344197
CP27A_HUMANCYP27A1physical
26344197
ENPL_HUMANHSP90B1physical
26344197
IMA3_HUMANKPNA4physical
26344197
SYMC_HUMANMARSphysical
26344197
MCM7_HUMANMCM7physical
26344197
PYC_HUMANPCphysical
26344197
RPN1_HUMANRPN1physical
26344197
STOM_HUMANSTOMphysical
26344197
TCPA_HUMANTCP1physical
26344197
QCR2_HUMANUQCRC2physical
26344197
TBD_HUMANTUBD1physical
28514442
DCA12_HUMANDCAF12physical
28514442
TCPH_HUMANCCT7physical
28514442
DTL_HUMANDTLphysical
28514442
WDR70_HUMANWDR70physical
28514442
DCA13_HUMANDCAF13physical
28514442
JMJD4_HUMANJMJD4physical
28514442
TCPB_HUMANCCT2physical
28514442
TCPW_HUMANCCT6Bphysical
28514442
TCPD_HUMANCCT4physical
28514442
KLHL8_HUMANKLHL8physical
28514442
MEP50_HUMANWDR77physical
28514442
WDR46_HUMANWDR46physical
28514442
BUB3_HUMANBUB3physical
28514442
TCPA_HUMANTCP1physical
28514442
FBXW8_HUMANFBXW8physical
28514442
TCPZ_HUMANCCT6Aphysical
28514442
KLD8B_HUMANKLHDC8Bphysical
28514442
TCPQ_HUMANCCT8physical
28514442
MAP2_HUMANMETAP2physical
28514442
TCPE_HUMANCCT5physical
28514442
PHLP_HUMANPDCLphysical
28514442
UTP18_HUMANUTP18physical
28514442
HDAC3_HUMANHDAC3physical
28514442
PDCL3_HUMANPDCL3physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TCPG_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-222, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-254, AND MASSSPECTROMETRY.

TOP